22590-92-7 Usage
Uses
Used in Pharmaceutical Research:
4-(Hydrazinocarbonyl)benzamide is used as a research compound for its anti-inflammatory and analgesic properties, making it a candidate for the development of new medications targeting pain and inflammation.
Used in Cancer Treatment Research:
In the field of oncology, 4-(Hydrazinocarbonyl)benzamide is being studied for its potential use in the treatment of various types of cancer. Its specific role and mechanism in cancer therapy are under investigation.
Used in Neurological Disorder Research:
4-(Hydrazinocarbonyl)benzamide is also being explored for its potential applications in the treatment of neurological disorders. The exact manner in which it may contribute to the management or treatment of such conditions is a subject of ongoing research.
Used as a Precursor in Synthesis:
4-(Hydrazinocarbonyl)benzamide has demonstrated its utility as a precursor in the synthesis of other bioactive compounds. Its role in chemical synthesis allows for the creation of new pharmaceuticals and other biologically active substances that can be used in various applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 22590-92-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,5,9 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 22590-92:
(7*2)+(6*2)+(5*5)+(4*9)+(3*0)+(2*9)+(1*2)=107
107 % 10 = 7
So 22590-92-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N3O2/c9-7(12)5-1-3-6(4-2-5)8(13)11-10/h1-4H,10H2,(H2,9,12)(H,11,13)
22590-92-7Relevant academic research and scientific papers
Design, synthesis, and evaluation of simple phenol amides as ERRγ agonists
Lin, Hua,Doebelin, Christelle,Patouret, Rémi,Garcia-Ordonez, Ruben D.,Ra Chang, Mi,Dharmarajan, Venkatasubramanian,Bayona, Claudia Ruiz,Cameron, Michael D.,Griffin, Patrick R.,Kamenecka, Theodore M.
, p. 1313 - 1319 (2018/03/21)
Herein we report the design and synthesis of a series of simple phenol amide ERRγ agonists based on a hydrazone lead molecule. Our structure activity relationship studies in this series revealed the phenol portion of the molecule to be required for activity. Attempts to replace the hydrazone with more suitable chemotypes led to a simple amide as a viable alternative. Differential hydrogen-deuterium exchange experiments were used to help understand the structural basis for binding to ERRγ and aid in the development of more potent ligands.
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
-
Page/Page column 37, (2008/12/07)
Provided herein are Heterocyclic Compounds having the following structure: wherein R1, R2, X, Y and Z are as defined herein, compositions comprising an effective amount of a Heterocyclic Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heterocyclic Compound to a patient in need thereof.
